USPTO trademark

NGEN

Under examinationUSPTOWord markClass 5Class 42

"NGEN" is a word mark owned by Orbis Medicines ApS, filed at the USPTO on July 23, 2026. It is under examination and covers classes 5 and 42.

Get this data via the API
Official USPTO record
NGEN trademark as filed
As filed with the USPTO
Status
Under examination
Since October 22, 2026
Filed
July 23, 2026
Registered
Not yet
Priority date
July 6, 2026
Claimed from European Union
Application no.
50009025
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
2 classes
Ownership

Who owns NGEN

The owner and representative on file with the office.

Owner

Orbis Medicines ApS

Vejle Øst, Denmark

Representative

Julie A. Greenberg

Reising Ethington P.C.

Goods and services

What the mark covers

The products and services NGEN is filed for, grouped by Nice class.

  • Medicine for the treatment, prevention, or alleviation of rare and genetic diseases, cancer, precancerous diseases and benign tumors, diabetes, autoimmune diseases, inflammatory diseases, infectious diseases, neurodegenerative diseases, neuromuscular disorders, psychiatric disorders, movement disorders, extrapyramidal disorders, hyperkinetic movement disorders, hypokinetic movement disorders, parkinsonism, Parkinson's disease, sclerosis, gastrointestinal disorders and diseases, diarrhea, metabolic diseases, inborn errors of metabolism, lysosomal storage diseases, urea cycle disorders, cardiovascular diseases, neurodevelopmental disorders, cardiometabolic diseases

  • Development of pharmaceutical preparations and medicines

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notification of letter of suspension e-mailed
  2. Letter of suspension e-mailed
  3. Suspension letter written
  4. Assigned to examiner
  5. New application office supplied data entered
  6. Application filing receipt mailed
  7. New application entered
FAQ

About NGEN

Who owns the trademark "NGEN"?

The USPTO trademark "NGEN" (application 50009025) is owned by Orbis Medicines ApS.

What is the status of "NGEN"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull NGEN and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019f943a-4d2a-75b7-8a98-99596d36406d
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019f943a-4d2a-75b7-8a98-99596d36406d",
  "object": "trademark",
  "mark_text": "NGEN",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50009025",
  "filing_date": "2026-07-23",
  "nice_classes": [
    5,
    42
  ],
  "owners": [
    {
      "name": "Orbis Medicines ApS",
      "entity_id": null
    }
  ]
}